Fatima Banine
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Fatima Banine has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Ben Emery
Jungers Center for Neurosciences Research, Department of Neurology, Oregon Health & Science University, Portland, USA
1 shared publication - Bruce Baggenstoss
Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma city, Oklahoma, USA
1 shared publication Daniel L. Marks
Department of Pediatrics, Oregon Health & Science University (OHSU), Portland, Oregon, USA
1 shared publication- Daniel Shaver
Department of Pediatrics, Oregon Health & Science University (OHSU), Portland, Oregon, USA
1 shared publication - Edward N. Harris
Department of Biochemistry, University of Nebraska, Lincoln, Nebraska, USA
1 shared publication Justin M. Dean
Department of Pediatrics, Oregon Health & Science University (OHSU), Portland, Oregon, USA
1 shared publication
Latest Publications
- Open Access
- 16 April 2018
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 128 (5) , 2025-2041
A TLR/AKT/FoxO3 immune tolerance–like pathway disrupts the repair capacity of oligodendrocyte progenitors
Cerebral white matter injury (WMI) persistently disrupts myelin regeneration by oligodendrocyte progenitor cells (OPCs). We identified a specific bioactive hyaluronan fragment (bHAf) that downregulates myelin gene expression and chronically blocks OPC maturation and myelination via a tolerance-like mechanism that dysregulates pro-myelination signaling via AKT. Desensitization of AKT occurs via TLR4 but not TLR2 or CD44. OPC differentiation was selectively blocked by bHAf in a maturation-dependent fashion at the late OPC (preOL) stage by a noncanonical TLR4/TRIF pathway that induced persistent activation of the FoxO3 transcription factor downstream of AKT. Activated FoxO3 selectively localized to oligodendrocyte lineage cells in white matter lesions from human preterm neonates and adults with multiple sclerosis. FoxO3 constraint of OPC maturation was bHAf dependent, and involved interactions at the FoxO3 and MBP promoters with the chromatin remodeling factor Brg1 and the transcription factor Olig2, which regulate OPC differentiation. WMI has adapted an immune tolerance–like mechanism whereby persistent engagement of TLR4 by bHAf promotes an OPC niche at the expense of myelination by engaging a FoxO3 signaling pathway that chronically constrains OPC differentiation.
- 16 April 2018
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 128 (5) , 2025-2041
Open AccessA TLR/AKT/FoxO3 immune tolerance–like pathway disrupts the repair capacity of oligodendrocyte progenitors
Cerebral white matter injury (WMI) persistently disrupts myelin regeneration by oligodendrocyte progenitor cells (OPCs). We identified a specific bioactive hyaluronan fragment (bHAf) that downregulates myelin gene expression and chronically blocks OPC maturation and myelination via a tolerance-like mechanism that dysregulates pro-myelination signaling via AKT. Desensitization of AKT occurs via TLR4 but not TLR2 or CD44. OPC differentiation was selectively blocked by bHAf in a maturation-dependent fashion at the late OPC (preOL) stage by a noncanonical TLR4/TRIF pathway that induced persistent activation of the FoxO3 transcription factor downstream of AKT. Activated FoxO3 selectively localized to oligodendrocyte lineage cells in white matter lesions from human preterm neonates and adults with multiple sclerosis. FoxO3 constraint of OPC maturation was bHAf dependent, and involved interactions at the FoxO3 and MBP promoters with the chromatin remodeling factor Brg1 and the transcription factor Olig2, which regulate OPC differentiation. WMI has adapted an immune tolerance–like mechanism whereby persistent engagement of TLR4 by bHAf promotes an OPC niche at the expense of myelination by engaging a FoxO3 signaling pathway that chronically constrains OPC differentiation.